Share this article:
Meet and Greet with Dr. Suhkai
Mahadeo Sukhai, PhD, University of Toronto and Ontario Cancer Institute, Toronto, ON, Canada
Affiliations and Expertise: Research Fellow and Team Leader, University Health Network, Princess Margaret Hospital, Ontario Cancer Institute, Toronto, ON, Canada
On Feb. 18th, 2017 during the American Association for the Advancement of Sciences, Dr. Sukhai will be stopping by the Elsevier booth for a meet greet. This year’s event will be held at the Hynes Convention Center in Boston, MA.
Dr. Mahadeo Sukhai is the world’s first congenitally blind cancer geneticist. Dr. Sukhai is currently a team leader with the Advanced Molecular Diagnostics Laboratory at the University Health Network in Toronto, Canada, where he leads the lab’s Variant Interpretation Group. In this role, he is responsible for the development and implementation of new methods to interpret the results of genomic tests for cancer, based on the results of the worldwide efforts to understand the cancer genome. As part of this effort, he is one of a team of scientists at the forefront of bringing new genomic technologies into the clinical setting.
Prior to assuming this role, Dr. Sukhai completed his PhD in cancer biology from the University of Toronto (2007), and two postdoctoral fellowships, in genomics and drug discovery, at the University Health Network. Dr. Sukhai also has a significant interest in higher education and the nature of the research training environment, with an emphasis on students and research trainees with disabilities.
Outside of a distinguished research and teaching career, Dr. Sukhai places a strong emphasis on voluntarism, science education, and mentorship. He has been an active volunteer with the International Association of Lions Clubs (1993–2003), the Let’s Talk Science Partnership Program (2007–12), the University of Toronto (2001–present), the Canadian National Institute for the Blind (CNIB; 2007–present), and the National Educational Association of Disabled Students (NEADS; 2004–present).
He has held numerous volunteer executive leadership positions at local, regional, national, and international levels, and currently serves as senior advisor to the NEADS Board of Directors. Dr. Sukhai recently completed a 3-year term as vice-chair of the Board of Directors of the National Postdoctoral Association (NPA). Dr. Sukhai joined the Research Committee of the CNIB in 2009, the National Board of Directors in 2012, and is currently the chair of the CNIB’s Public Education and Advocacy Committee as well as a mentor to CNIB’s National Youth Council.
Dr. Sukhai is also the chair of the National Taskforce on the Experience of Graduate Students with Disabilities, established by NEADS, where he led a nationwide intensive multistakeholder effort to understand the barriers faced by graduate students with disabilities in Canadian postsecondary education—a landmark, first-of-its-kind study with significant national and international impact. He is also the executive director of the NEADS National Student Awards Program, Canada’s only nationwide cross-discipline and cross-disability scholarship program, and is the principal investigator of a series of projects exploring the culture of accessibility in science laboratories and other practical spaces.
Dr. Sukhai was most recently a member of the 2015 Governor General’s Canadian Leadership Conference, and has been recognized numerous times for his contributions to science, higher education, and volunteerism.
Come visit the Elsevier booth this Saturday, February 18, 2017 from 12:30pm- 1:30pm to meet and speak with Dr. Sukhai!!
For limited time, access his book Creating a Culture of Accessibility in the Sciences. Click here to access his book on ScienceDirect! Or visit the Elsevier store to reserve your copy today and receive 30% off with promo code STC317.
Biomedicine & Biochemistry
The disciplines of biomedicine and biochemistry impact the lives of millions of people every day. Research in these areas has led to practical applications in cardiology, cancer treatment, respiratory medicine, drug development, and more. Interdisciplinary fields of study, including neuroscience, chemical engineering, nanotechnology, and psychology come together in this research to yield significant new discoveries. Elsevier’s biomedicine and biochemistry content spans a wide range of subject matter in various forms, including journals, books, eBooks, and online information services, enabling students, researchers, and clinicians to advance these fields. Learn more about our Biomedical and Biochemistry books here.